Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Disease Activity Free Status: A New End Point for a New Era in Multiple Sclerosis Clinical Research?
Early Postnatal Myelin Content Estimate of White Matter via T1w/T2w Ratio.
[Neuromyelitis optica spectrum disorders as initial presentation of Sjögren's syndrome: A case report].
OnabotulinumtoxinA is Effective in Patients with Urinary Incontinence due to Neurogenic Detrusor Activity Regardless of Concomitant Anticholinergic Use or Neurologic Etiology.
Deep grey matter MRI abnormalities and cognitive function in relapsing-remitting multiple sclerosis.
Histogram analysis of apparent diffusion coefficient maps for differentiating primary CNS lymphomas from tumefactive demyelinating lesions.
The effect of glia-glia interactions on oligodendrocyte precursor cell biology during development and in demyelinating diseases.
Evaluating sex hormone levels in reproductive age women with multiple sclerosis and their relationship with disease severity.
The effect of exercise training on fitness in multiple sclerosis: A meta-analysis.
Primary progressive multiple sclerosis: progress and challenges.
Best Practices in Alemtuzumab Administration: Practical Recommendations for Infusion in Patients With Multiple Sclerosis.
Agent based modeling of the effects of potential treatments over the blood-brain barrier in multiple sclerosis.
Efficient generation of myelinating oligodendrocytes from primary progressive multiple sclerosis patients by induced pluripotent stem cells.
Relationship between vitamin D deficiency and visually evoked potentials in multiple sclerosis.
Is environmental radon gas associated with the incidence of neurodegenerative conditions? A retrospective study of multiple sclerosis in radon affected areas in England and Wales.
Predicting outcome in clinically isolated syndrome using machine learning.
Epstein Barr virus is not a characteristic feature in the central nervous system in established multiple sclerosis.
Immune cell dynamics in the CNS: Learning from the zebrafish.
Midkine and multiple sclerosis.
Disease mechanisms in MS: Neuronal network connectivity is altered in multiple sclerosis.
Role Preferences of People with Multiple Sclerosis: Image-Revised, Computerized Self-Administered Version of the Control Preference Scale.
Critical role of the Mac1/NOX2 pathway in mediating reactive microgliosis-generated chronic neuroinflammation and progressive neurodegeneration.
Socioeconomic Factors in Childhood and the Risk of Multiple Sclerosis.
Age of the Donor Reduces the Ability of Human Adipose-Derived Stem Cells to Alleviate Symptoms in the Experimental Autoimmune Encephalomyelitis Mouse Model.
Altered thalamic functional connectivity in multiple sclerosis.
Pages
« first
‹ previous
…
474
475
476
477
478
479
480
481
482
…
next ›
last »